Our findings of a moderate to strong correlation between TIBs and IL-1β in DCIS samples suggest that B cells may negatively impact early disease stages by activating the IL-1-NFκB signaling pathway and its downstream targets, which promote extracellular matrix degradation and increase invasiveness. This evidence concerns the gene IL1A and ductal breast carcinoma in situ.